Opinion
Video
Kara Cossis, PA-C, MPH, on the role of APPs in genetic testing
Author(s):
Key Takeaways
- Advanced practice providers are key in educating patients about genetic testing for prostate cancer and its implications for treatment.
- APPs interpret genetic test results and guide treatment decisions, either within their practice or through referrals to oncology partners.
APPs can help in introducing genetic testing and in the interpretation of results, according to Kara Cossis, PA-C, MPH.
In this video, Kara Cossis, PA-C, MPH, discusses the role of advanced practice providers (APPs) in expanding and encouraging the use of genetic testing for prostate cancer. Cossis is a physician assistant at Chesapeake Urology in Towson, Maryland.
Video Transcript:
I think there's a very good role for APPs to introduce the genetic testing to the patients to help explain what exactly we're testing for, why we're testing for it, what it means potentially for their cancer treatments. And then, as the results come back, to be able to review the results with a patient. But then also, [to] know how to interpret them, to either be able to treat them internally with the practice—if those particular treatments exist—or to refer them out, say to a partner with medical oncology if there's additional treatments they qualify for, but they may not have in house.
This transcript was AI generated and edited by human editors for clarity.
